Results of phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with chemoradiotherapy in patients with rectal cancer

Authors

Po‐Li Wei (ORCID: https://orcid.org/0000-0002-7275-2661)
Huang‐Ming Hu (ORCID: https://orcid.org/0000-0002-3954-1117)
Bor-Nian Shen
Ching‐Wen Huang (ORCID: https://orcid.org/0000-0001-8011-8428)
Jaw‐Yuan Wang (ORCID: https://orcid.org/0000-0002-7705-2621)
Ming‐Yii Huang (ORCID: https://orcid.org/0000-0001-9432-5284)
Chou-Pin Chen (ORCID: https://orcid.org/0000-0002-8844-2203)
Tsung‐Kun Chang (ORCID: https://orcid.org/0000-0001-9760-5070)
Chiao‐Yun Chen (ORCID: https://orcid.org/0000-0003-4113-2547)
Wen‐Hung Hsu

Institutions

Kaohsiung Medical University (TW)
Taipei Medical University Hospital (TW)
Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
Taichung Veterans General Hospital (TW)

Publication Details

Journal: Nanomedicine
Published: 2025-04-21
DOI: https://doi.org/10.1080/17435889.2025.2487411
Citations: 2
Primary Topic: Colorectal Cancer Surgical Treatments
Type: article
Field-Weighted Citation Impact: 2.09

Funders

Ministry of Health and Welfare
Kaohsiung Medical University Chung-Ho Memorial Hospital

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Results of phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with chemoradiotherapy in patients with rectal cancer

Po‐Li Wei, Huang‐Ming Hu, Bor-Nian Shen, Ching‐Wen Huang et al.

Apr 21, 2025

2 citations

Nanomedicine

Colorectal Cancer Surgical Treatments

2.09

article

Results of phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with chemoradiotherapy in patients with rectal cancer

Po‐Li Wei, Huang‐Ming Hu, Bor-Nian Shen, Ching‐Wen Huang, Jaw‐Yuan Wang, Ming‐Yii Huang, Chou-Pin Chen, Tsung‐Kun Chang, Chiao‐Yun Chen, Wen‐Hung Hsu

April 21, 2025article en

2 citations

Abstract

No abstract available for this paper.

NanomedicineVol. 20(9)

Kaohsiung Medical University (TW), Taipei Medical University Hospital (TW), Kaohsiung Medical University Chung-Ho Memorial Hospital (TW), Taichung Veterans General Hospital (TW)

Ministry of Health and Welfare, Kaohsiung Medical University Chung-Ho Memorial Hospital

Good health and well-being

Openalex Percentile: Top 13%

Colorectal Cancer Surgical Treatments

2.09

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Results of phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with chemoradiotherapy in patients with rectal cancer — Po‐Li Wei, Huang‐Ming Hu, et al. · Nanomedicine (2025) | TGRS Research Map | TGRS